Syncom Formulation (India) Ltd

SYNCOMF

Company Profile

  • Business description

    Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

  • Contact

    207, Saket Nagar
    Near Saket Club
    IndoreMP452018
    IND

    T: +91 7312560458

    https://www.sfil.in

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    2,122

Stocks News & Analysis

stocks

Going into earnings, is Netflix stock a buy, a sell, or fairly valued?

Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.
stocks

Bapcor is paying for the sins of its past

Shares plunged over 17% after reporting disappointing results.
stocks

Overvalued ASX share as market underestimates downside risks

Growth outlook solid, but upside more than priced in.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,390.1016.400.17%
CAC 408,225.7319.660.24%
DAX 4024,264.295.490.02%
Dow JONES (US)46,830.55123.970.27%
FTSE 1009,407.223.650.04%
HKSE26,027.55168.720.65%
NASDAQ22,939.7350.81-0.22%
Nikkei 22549,316.06130.560.27%
NZX 50 Index13,377.8532.890.25%
S&P 5006,732.133.00-0.04%
S&P/ASX 2009,094.7018.800.21%
SSE Composite Index3,916.3352.441.36%

Market Movers